Anzu Special Acquisition I announced that its stockholders voted to approve the business combination with Envoy Medical.
Over 99% of the votes cast were in favor of the merger, the SPAC said.
Subject to the satisfaction or waiver of other closing conditions, the deal is expected to close tomorrow, Sept. 29, which is the day before Anzu’s termination deadline.
Envoy Medical stock and warrants are expected to begin trading on the Nasdaq under the symbols COCH and COCHW.
Envoy has developed an FDA-approved cochlear implant to aid individuals with severe hearing loss.
Terms at deal announcement in April called for Envoy to receive 15 million Anzu I shares at $10 each.
Because Anzu cancelled an extension vote originally scheduled for tomorrow, the SPAC in an 8-K said it will not complete the redemption of shares of submitted in connection with the extension proposal. The number of redeemed shares was not disclosed in the regulatory filing. Read more.
